A Retrospective Analysis of Factors Affecting Palliative Care Consults in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.

barriers to consultation cytoreductive surgery gi oncology hyperthermic intraperitoneal chemotherapy palliative and supportive care quality of life (qol)

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
09 Jan 2021
Historique:
entrez: 12 2 2021
pubmed: 13 2 2021
medline: 13 2 2021
Statut: epublish

Résumé

Purpose This study was conducted to determine factors that influence palliative care (PC) consultation in patients receiving cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). Patient and methods We queried our Electronic Medical Record EPIC for a list of patients who underwent cytoreductive surgery with HIPEC or hyperthermic intrathoracic chemotherapy (HITEC) in the hospital from April 2016-April 2019. Data was manually extracted and patients who did not meet our criteria were excluded. Patients were divided on the basis of palliative care consults and differences between the groups were analyzed. Odds ratios (OR) with p-value of 0.05 and confidence interval of (CI) 95% were calculated. Results We identified 55 patients of whom 34 met our inclusion criteria: 11 males and 23 females with an average age of 56 years at the time of diagnosis. Eight patients (23%) had PC, with six having commercial insurance, seven married, and six with more than one comorbid medical issue. Comorbidities >1 (OR: 0.12; CI: 0.02-0.76; p: 0.02) and age >40 (OR: 0.015; CI: 0.0007-0.3029; P: 0.006) were associated with a higher likelihood of PC. Gender, insurance type, and marital status did not have a significant association with PC. Mean age between PC consulted patients versus non-PC consulted patients was 58.5 vs. 55.9 and median age between the two groups was 60.5 vs. 60 which also showed a trend towards higher rates of PC in the older population. Conclusion Approximately one quarter of patients who underwent CRS with HIPEC had a concurrent PC consult. Though this is better than the national average of 11-16%, it continues to be a very small number. Efforts must be made to engage PC early in the course of treatment and recognize it as an integral part of cancer care. PC is not only an end-of-life service, in fact, studies have shown that early consultations lead to higher patient satisfaction, improved quality of life, and better communication.

Identifiants

pubmed: 33575150
doi: 10.7759/cureus.12589
pmc: PMC7870133
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e12589

Informations de copyright

Copyright © 2021, Rodriguez et al.

Déclaration de conflit d'intérêts

The authors have declared financial relationships, which are detailed in the next section.

Références

Transl Gastroenterol Hepatol. 2016 Aug 12;1:63
pubmed: 28138629
J Oncol Pract. 2017 Sep;13(9):e703-e711
pubmed: 28783424
Am Fam Physician. 2013 Dec 15;88(12):807-13
pubmed: 24364543
Palliat Care. 2017 Feb 20;10:1178224216688887
pubmed: 28469439
N Engl J Med. 2010 Aug 19;363(8):733-42
pubmed: 20818875
J Ovarian Res. 2019 Apr 17;12(1):33
pubmed: 30995948
Melanoma Res. 2018 Feb;28(1):56-60
pubmed: 29023264
Crit Care Nurse. 2015 Oct;35(5):44-52
pubmed: 26427974
J Gastrointest Oncol. 2016 Feb;7(1):99-111
pubmed: 26941988

Auteurs

Robin R Rodriguez (RR)

Medical Oncology, Allegheny Health Network, Pittsburgh, USA.

Laila Babar (L)

Medical Oncology, The University of Iowa Hospitals and Clinics, Iowa City, USA.

Herman Lo (H)

Medical Oncology, Allegheny Health Network, Pittsburgh, USA.

Obaid Ashraf (O)

Internal Medicine, Allegheny Health Network, Pittsburgh, USA.

Dulabh Monga (D)

Hematology and Oncology, Allegheny Health Network, Pittsburgh, USA.

Gene Finley (G)

Hematology and Oncology, Allegheny Health Network, Pittsburgh, USA.

Lisa Doverspike (L)

Palliative Care, Butler Health System, Butler, USA.

Amber Blackledge (A)

Palliative Care, Butler Health System, Butler, USA.

Ashish Sethi (A)

Medical Oncology, Allegheny Health Network, Pittsburgh, USA.

Moses S Raj (MS)

Hematology and Oncology, Allegheny Health Network, Pittsburgh, USA.

Classifications MeSH